anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
Regional anesthesia in children has become increasingly popular over the past few decades. A variety of peripheral and central nerve blocks have been developed to ensure that perioperative pain can be effectively controlled. So, it possible to reduce the dose concentrations of systemic drugs and improved hemodynamic stability in high-risk patients. Erector spinae plane (ESP) block with various approaches been used in many surgeries and obtained great popularity despite of its novelty. After first description; lower thoracic, lumbar and sacral approaches were defined for postoperative analgesia. There are a few cases in which sacral ESP block was administered and reported.

The aim of this study is to compare postoperative analgesic effect of ultrasound guided sacral ESP block and caudal block. It is hypothesized that sacral ESP block will be comparable to caudal block as a promising effective alternative for analgesia in patients who will undergo pediatric anorectal surgery with fewer side effects.

This prospective, randomized, comparative clinical study will include 60 children who will be scheduled for elective anorectal surgery under general anesthesia in Mansoura university hospitals. Informed written consent will be obtained from parents of all subjects in the study after ensuring confidentiality. The study protocol will be explained to parents of all patients in the study who will be kept fasting prior to surgery. Patients will be randomly assigned to two equal groups (ESP and caudal) according to computer-generated table of random numbers using the permuted block randomization method. The collected data will be coded, processed, and analyzed using SPSS program. All data will be considered statistically significant if P value is ≤ 0.05.
Destruction of erythropoiesis process leads to various diseases, including thrombocytopenia, anaemia, and leukaemia. miR-429-CT10 regulation of kinase-like (CRKL) axis involved in development, progression and metastasis of cancers. However, the exact role of miR-429-CRKL axis in leukaemic cell differentiation are still unknown. The current work aimed to uncover the effect of miR-429-CRKL axis on erythropoiesis. In the present study, CRKL upregulation was negatively correlated with miR-429 downregulation in both chronic myeloid leukaemia (CML) patient and CR patient samples. Moreover, CRKL expression level was significantly decreased while miR-429 expression level was increased during the erythroid differentiation of K562 cells following hemin treatment. Functional investigations revealed that overexpression and knockdown of CRKL was remarkably effective in suppressing and promoting hemin-induced erythroid differentiation of K562 cells, whereas, miR-429 exhibited opposite effects to CRKL. Mechanistically, miR-429 regulates erythroid differentiation of K562 cells by downregulating CRKL via selectively targeting CRKL-3'-untranslated region (UTR) through Raf/MEK/ERK pathway. Conversely, CRKII had no effect on erythroid differentiation of K562 cells. Taken together, our data demonstrated that CRKL (but not CRKII) and miR-429 contribute to development, progression and erythropoiesis of CML, miR-429-CRKL axis regulates erythropoiesis of K562 cells via Raf/MEK/ERK pathway, providing novel insights into effective diagnosis and therapy for CML patients.
In the first session participants will received the 6 basic principles of the technique. All the other sessions will last 50 minutes and consist of warm-up, main program and cool-down exercises. The degree of difficulty of the exercises of the main part will progress every 2 weeks.
Colorectal surgery poses significant risks, with anastomotic disruption being a severe complication. Traditional management involves surgical intervention, contributing to postoperative morbidity and mortality. In this brief report, we present a 54-year-old woman with a history of diverticulitis, multiple surgeries, and anastomotic leak following ileorectal anastomosis. Attempts at managing anastomotic leaks with more minimally invasive approaches have been successful in esophageal surgery with the use of covered metallic stents. However, this approach has been rarely attempted for the management of colorectal anastomotic leaks. Instead of conventional surgical approaches, we employed an off-label use of an endoscopic covered metallic stent, WallFlex™, to successfully manage the anastomotic disruption. The patient's recovery was uneventful, highlighting the potential role of stents in select cases.
UNLABELLED: Nintedanib, a multi-intracellular tyrosine kinase inhibitor, reduces progression of idiopathic pulmonary fibrosis (IPF) and has been approved to use in other progressive fibrosing interstitial lung diseases (ILD) recently. However, the factors that affect the discontinuation of treatment due to adverse events is uncertain. The dorsal muscle group area at the T12 vertebral level (T12DMA) assessed on computed tomography (CT) images has been reported to be associated with mortality in chronic obstructive pulmonary disease (COPD) and other diseases. The relationship between T12DMA and the discontinuation of nintedanib remains unclear.
METHODS: 39 patients with IPF or other progressive fibrosing ILDs who started nintedanib at a regular dose (300 mg/day) were enrolled. We compared the characteristics between patients who stopped nintedanib at a regular dose before 6 months and/or continue to take nintedanib at a low dose (150 mg/day) and patients who were still taking nintedanib at a regular dose over 6 months. This study retrospectively investigated clinical parameters including T12DMA index (T12DMA/height2) to evaluate whether these parameters might serve as risk factor for the tolerability of nintedanib in patients with IPF and other progressive fibrosing ILDs.
RESULTS: Discontinuation or dose reductions of nintedanib due to adverse events were observed in 14 (35.8%) patients. A multiple logistic regression model showed T12DMA index to be the only significant risk factor for predicting for the early termination of nintedanib (odd rate, 0.549; 95% confidence interval, 0.327-0.922; P = .023).
CONCLUSIONS: This study revealed that T12DMA index was a risk factor for the early termination of nintedanib. The initial dose of nintedanib adjusted to the differences in skeletal muscle mass and careful management of adverse events may contribute to the longer nintedanib treatment, which would lead to a better clinical outcome.
Osteoarthritis (OA) of the 1st carpometacarpal (CMC) joint is a significant cause of hand pain, dysfunction, disability, and visible deformity. Surgery in the form of ligament reconstruction and tendon interposition (LRTI)is often indicated when less invasive procedures fail. Following LRTI procedures, the accepted classic protocol throughout the literature has been to place patients in a thumb-immobilizing spica cast or splint for 4-6 weeks and then begin rehabilitation exercises. Following this, a gradual progressive rehabilitation protocol is initiated which usually focuses on thumb range of motion, pinch strength, and hand function. This standard form of rehabilitation has shown improvements in pain, function, and satisfaction. However, because these patients are usually kept immobilized until 4-6 weeks post-operatively in order for the tendon graft to incorporate and become stable, stiffness can develop in the thumb as a result. This leads to more time off work and without full and unrestricted use of the hand. Due to their higher pullout strength compared to conventional tendon fixation, the use of interference screws in LRTI procedures may allow for earlier initiation of a more accelerated rehabilitation protocol compared to the standard 4-6 weeks of immobilization prior to rehabilitation. Over the past year at the investigators center the investigators have begun post-operative mobilization and rehabilitation on the first post-op visit at 10-14 days following LRTI with the use of an interference screw. Anecdotally, the investigators have found that their patients have regained their range of motion and function earlier and, in some cases, with larger gains compared to their previous patients they had immobilized for 6 weeks before initiating their rehabilitation. The purpose of this study is to compare patients that have been exposed to the early versus standard rehabilitation protocol to see if there is significant improvement in their range of motion, pinch and grip strength, pain levels and function.
Repeated MRI and DMI for simplification of protocols. Repeated within 6 +/- 2 weeks.
BACKGROUND: Genetic factors contribute to chronic kidney disease (CKD) and end-stage renal disease (ESRD). Advances in genetic testing have enabled the identification of hereditary kidney diseases, including those caused by LMX1B mutations. LMX1B mutations can lead to nail-patella syndrome (NPS) or nail-patella-like renal disease (NPLRD) with only renal manifestations.
CASE PRESENTATION: The proband was a 13-year-old female who was diagnosed with nephrotic syndrome at the age of 6. Then she began intermittent hormone and drug therapy. When she was 13 years old, she was admitted to our hospital due to sudden chest tightness, which progressed to end-stage kidney disease (ESRD), requiring kidney replacement therapy. Whole-Exome Sequencing (WES) results suggest the presence of LMX1B gene mutation, c.737G > T, p.Arg246Leu. Tracing her family history, we found that her father, grandmother, uncle and 2 cousins all had hematuria, or proteinuria. In addition to the grandmother, a total of 9 members of the family performed WES. The members with kidney involved all carry the mutated gene. Healthy members did not have the mutated gene. It is characterized by co-segregation of genotype and phenotype. We followed the family for 9 year, the father developed ESRD at the age of 50 and started hemodialysis treatment. The rest patients had normal renal function. No extra-renal manifestations associated with NPS were found in any member of the family.
CONCLUSIONS: This study has successfully identified missense mutation, c.737G > T (p.Arg246Leu) in the homeodomain, which appears to be responsible for isolated nephropathy in the studied family. The arginine to leucine change at codon 246 likely disrupts the DNA-binding homeodomain of LMX1B. Previous research has documented 2 types of mutations at codon R246, namely R246Q and R246P, which are known to cause NPLRD. The newly discovered mutation, R246L, is likely to be another novel mutation associated with NPLRD, thus expanding the range of mutations at the crucial renal-critical codon 246 that contribute to the development of NPLRD. Furthermore, our findings suggest that any missense mutation occurring at the 246th amino acid position within the homeodomain of the LMX1B gene has the potential to lead to NPLRD.
Extracellular matrix (ECM) stiffness modulates a variety of cellular processes, including ferroptosis, a process with significant potential implications for hepatocellular carcinoma (HCC) fibrosis and cirrhosis. However, the exact relationship between ECM stiffness and HCC ferroptosis is yet unclarified, partially due to the lack of in situ information on key parameters of the ferroptosis process of living HCC cells. This study pioneers the use of in vitro mechanical microenvironment models of HCC and the scanning electrochemical microscopy (SECM) technique for understanding this interplay. We first cultured HuH7 cells on 4.0, 18.0, and 44.0 kPa polyacrylamide (PA) gels to simulate early, intermediate, and advanced HCC ECM stiffness, respectively. Then, we used SECM to in situ monitor changes in cell membrane permeability, respiratory activity, and reactive oxygen species (ROS) levels of erastin-induced HuH7 cells on PA gels, finding that increasing ECM stiffness potentiates ferroptosis, including increased membrane permeabilization and H2O2 release as well as reduced respiratory activity. Through further transcriptome sequencing and molecular biology measurements, we identified a critical role for focal adhesion kinase (FAK)-mediated yes-associated protein (YAP) in regulating the ferroptosis process dependent on ECM stiffness, which provides novel insights into the mechanical regulation of ferroptosis in HCC cells and may pave the way for innovative therapeutic strategies.
All participants will receive background local standard of care therapy according to participating institutions/hospitals regardless of the study group to which they belong. 60 participants will be recruited to this study. 30 patients in the CCD arm and 30 patients in the FTD.
The invention relates to a grape wine with cold prevention efficacy. The grape wine comprises the following components by mass: 70-80 parts of grape wine, 10-20 parts of a honeysuckle extract, 5-10 parts of a Cyrtomium rhizome extract, 5-10 parts of a Folium Isatidis extract, and 0-15 parts of other Chinese herbal extracts. The grape wine is composed of two or three of Cabernet Sauvignon, Cabernet Gernischet and Cabernet Franc. The other Chinese herbal extracts can be over one or two of a Radix Isatidis extract, a Spica Schizonepetae extract, and a Herba Periliae extract. The grape wine provided in the invention has mellow taste and fragrant smell. The adding of appropriate amounts of drug extract components does not affect the taste of the grape wine itself. Multiple drug components and the intrinsic beneficial substances of grape wine are merged together, thus achieving a cold prevention effect.
<P>PROBLEM TO BE SOLVED: To provide a sheet for applying charcoal powder on the skin easily expressing efficacy of the charcoal and easy to handle.  <P>SOLUTION: The invention relates to the three layered type sheet obtained by mixing the charcoal powder with a viscous polymer in high mixing ratio to inhibit scattering of the powder and then pasting the mixture on a fabric and then integrating them with a releasing film and the sheet is applied to the skin by releasing the releasing film as needed. Falling of the charcoal powder is substantially prevented by laminating a thin pressure sensitive layer on the viscous substrate layer with charcoal powder. The black color is obscured by using a white colored pressure sensitive layer. A sustained release sheet is obtained by absorbing medicine on the charcoal of the sheet.  <P>COPYRIGHT: (C)2006,JPO&NCIPI
Suicidality and Antidepressant Drugs 

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of venlafaxine hydrochloride or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Venlafaxine hydrochloride tablets are not approved for use in pediatric patients. (See WARNINGS: Clinical Worsening and Suicide Risk, PRECAUTIONS: Information for Patients, and PRECAUTIONS: Pediatric Use).
The invention belongs to the technical field of biomedicine, and provides an application of human umbilical cord mesenchymal stem cell derived mitochondria in preparing medicaments for inhibiting heart failure and myocardial damage in order to solve the problem of lack of medicaments for targeted protection of heart at present. Further applied to the preparation of medicaments for repairing heart failure myocardial mitochondrial damage and delaying myocardial cell apoptosis. The present invention tracks the overall process of single mitochondrial transplantation into recipient cells, with human-specific mitochondrial DNA occurring in mouse myocardium and HL-1 cells after transplantation. Through the heart failure model, it was demonstrated that MSC-Mito transplantation can protect cardiac function and prevent myocardial apoptosis. Through RNA sequencing and validation experiments, it was found that MSC-Mito transplants may play a cardioprotective role by restoring ATP production and inhibiting AMPK alpha/mTOR mediated excessive autophagy. MSC-Mito transplantation may provide a new therapeutic strategy for heart failure patients.
SAR442085 will be given intravenously weekly for 4 weeks (Cycle 1) and on Day 1 and Day 15 of each subsequent cycle until the patient has progressive disease, unacceptable toxicity or other reasons to terminate study treatment. Each cycle will be approximately 28 days in duration.
PURPOSE:To prepare a stable emulsion, by dispersing a hydrophobic solid containing an alkali salt of a fatty acid as a surface active agent in an aqueous solution of a specific polymer, and thereafter adding a liquid, an organic acid, etc. to the dispersion to keep the pH value below a specific level, thereby converting the fatty acid alkali salt completely to the free fatty acid. CONSTITUTION:A hydrophobic solid composition containing an alkali salt of a fatty acid as a surface active agent is dispersed in an aqueous solution of a carboxyvinyl polymer, having an acidity of pH 2.5-4, and a known hydrophobic liquid base, e.g. hydrocarbons such as liquid paraffin, squalane, etc., esters such as isopropyl myristate, etc., is added thereto to give an emulsion. When the amount of the carboxyvinyl polymer is smaller than the amount required to neutralize the alkali salt of the fatty acid, an organic acid, e.g. lactic acid, citric acid, etc., is added to the emulsion to attain a pH value of <=7. The surface active agent is removed by this process, and an emulsion having stable properties with temperature and increased storage stability is obtained.
Nasolacrimal duct obstruction due to infection, inflammation, or excessive fibroblast proliferation may result in persistent tearing, intraocular inflammation, or even blindness. In this study, surface engineering techniques are applied to nasolacrimal duct stents for the first time. Based on the functioning of marine mussels, "one-pot" and "stepwise" methods were employed to construct a novel multifunctional superhydrophilic PDA/RAP coating using dopamine and rapamycin. Micron-sized rapamycin crystals combined with nano-sized polydopamine particles form a micro-nano topographical structure. Therefore, acting synergistically with in situ-generated hydrophilic groups (amino, carboxyl, and phenolic hydroxyl), they impart excellent and long-lasting superhydrophilicity to the nasolacrimal duct stent. The PDA/RAP coating effectively maintained the stability of the initial microenvironment during stent implantation by inhibiting the onset of acute inflammation and infection during the early stages of implantation. Meanwhile, the rapamycin crystals, supported by the superhydrophilic platform, exhibited a sustained-release capability that helped them to better exert their anti-inflammatory, antibacterial, and anti-fibroblast proliferative properties, ensuring conducive conditions for the rapid repair of nasolacrimal duct epithelial cells, verified by a series of experiments. In conclusion, the PDA/RAP hydrophilic coating has anti-inflammatory, antifibrotic, antibacterial, and antithrombotic properties, offering a new strategy to address restenosis following clinical nasolacrimal duct stent implantation.
Systems and methods for automatically detecting a disease in medical images are provided. Input medical images are received. A plurality of metrics for a disease is computed for each of the input medical images. The input medical images are clustered into a plurality of clusters based on one or more of the plurality of metrics to classify the input medical images. The plurality of clusters comprise a cluster of one or more of the input medical images associated with the disease and one or more clusters of one or more of the input medical images not associated with the disease. In one embodiment, the disease is COVID-19 (coronavirus disease 2019).
Patients receive tucatinib 200mg orally BID, osimertinib 80mg orally daily, and cetuximab 250mg/m\^2 IV every 2 weeks of a 28-day cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
PURPOSE: An eye makeup cosmetic composition containing cellulose powder or green tea powder is provided to ensure excellent application and rich volume without irritation to eye. CONSTITUTION: An eye makeup cosmetic composition contains cellulose powder or green tea powder for enhancing color and volume. The cellulose powder or green tea powder is cellulose-laked on microcrystal cellulose by mordanting agent. The green tea powder is complex compound by reaction of tannic acid and the mordanting agent. The mordanting agent is aliment, iron, copper or tin. The cellulose powder contains 0.1-99.0 weight parts of microcrystal cellulose, 0.10-20.0 weight parts of coloring material and 0.01-10.0 weight parts of mordanting agent. The cosmetic composition further contains 0.1-20 weight% of dispersing agent. The dispersing agent is sorbitan olivate or sodium metaphosphate.
PURPOSE:To provide the title composition excellent in decoloring power, capable of decoloration to white or pale yellow with treatment in a short time, causing no damage of hair quality, for decoloring animal hair such as of horses, containing a peroxide and an oxidizing agent, adjusted so as to given alkalinity. CONSTITUTION:The objective composition adjusted with e.g. ammonia so as to give alkalinity, containing (A) pref. 3 - 18wt.% of a peroxide (e.g. sodium persulfate) and (B) pref. 2 - 20wt.% of an oxidizing agent (e.g. hydrogen peroxide, sodium perborate).
To provide a medical care assisting device, an operation method for the medical care assisting device and an operation program for the medical care assisting device, with which it is possible to prevent precaution information for a pet owner from being overlooked.SOLUTION: A CPU of a medical care assisting server functions as an acceptance unit, a RW control unit, and a screen output control unit. The acceptance unit accepts precaution information for a pet owner as owner information. The RW control unit exercises control for storing the precaution information in a storage device. The screen output control unit outputs a health management screen for pets which is provided with a balloon display region which is exclusively used for the precaution information. An information mark indicating that there is precaution information is displayed on the health management screen. The balloon display region is displayed only when the information mark is selected.SELECTED DRAWING: Figure 13
A cohort of participants with suspected stable HFpEF will be recruited from the primary care setting. HFpEF diagnosis will be confirmed as per the 2016 European Society of Cardiology (ESC) guidelines for diagnosing HFpEF. All participants will undergo a series of assessments including but not limited to pulse wave velocity, 6 minute walk test, blood tests including natriuretic peptides (NT-Pro-BNP), ECG, physical assessments and a series of questionnaires. Those with confirmed HFpEF will be followed up at 6 and 12 months.